logo

DRREDDY vs GRASIM: Stock Comparison

DR. REDDY S LABORATORIES vs GRASIM INDUSTRIESUpdated 23 Oct 26, 4:08 PM ISTNSE & company filings

GRASIM INDUSTRIES is the larger company by market capitalisation. DR. REDDY S LABORATORIES shows a lower P/E, a higher ROE and a higher dividend yield, while GRASIM INDUSTRIES shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

DRREDDY leads 9; GRASIM leads 4 of 13

Not a rating
These companies operate in different sectors (Healthcare vs Construction Materials). Valuation and leverage norms differ across sectors, so cross-sector ratio comparisons can mislead — compare each against its own sector peers too.

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

DRREDDYGRASIM

Valuation lens

What price are you paying?

Market CapContext only
₹1.02 L Cr
₹1.97 L Cr
P/E RatioDRREDDY has the lower reading
31.71x ✓
34.64x
P/B RatioGRASIM has the lower reading
2.7x
1.91x ✓
EPSGRASIM has the higher reading
₹39.74
₹83.85 ✓
Book ValueContext only
₹460.31
₹1,525.54
Dividend YieldDRREDDY has the higher reading
0.64% ✓
0.35%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GRASIM is the larger company
₹1.97 L Cr vs ₹1.02 L Cr
P/E Ratio
DRREDDY has a lower P/E
31.71x vs 34.64x
P/B Ratio
GRASIM has a lower P/B
1.91x vs 2.7x
EPS
GRASIM has higher earnings per share
₹83.85 vs ₹39.74
Dividend Yield
DRREDDY has a higher dividend yield
0.64% vs 0.35%
Revenue Growth (TTM YoY)
GRASIM has faster revenue growth
10.5% vs -11.6%
EPS Growth (TTM YoY)
GRASIM has faster EPS growth
60.8% vs -86.2%
Qtr Sales Growth
DRREDDY has stronger quarterly sales growth
7.33% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDRREDDYGRASIM
SectorHealthcareConstruction Materials
IndustryPharmaceuticalsCement & Cement Products

Price

MetricDRREDDYGRASIM
Live Price₹1,229.5₹2,894
Day Change-0.77%-0.01%
Volume15.5 L3.14 L
52-Week High₹1,414.9₹3,411.1
52-Week Low₹1,101₹2,502.5
Distance from 52W High-13.1%-15.16%

Valuation

MetricDRREDDYGRASIM
Market Cap₹1.02 L Cr₹1.97 L Cr
P/E Ratio31.71x34.64x
P/B Ratio2.7x1.91x
EPS₹39.74₹83.85
Book Value₹460.31₹1,525.54
Dividend Yield0.64%0.35%

Growth

MetricDRREDDYGRASIM
Revenue Growth (TTM YoY)-11.6%10.5%
EPS Growth (TTM YoY)-86.2%60.8%
Qtr Sales Growth7.33%0%
Qtr Profit Growth96.84%0%

Profitability & Leverage

MetricDRREDDYGRASIM
ROE10.27%0.63%
ROCE12.07%1.57%
Net Margin12.76%2.83%
Operating Margin21.43%3.26%
Debt to Equity0.17x0.21x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricDRREDDYGRASIM
Promoter Holding26.64%▲ 0.01 pp40.6%▲ 1.46 pp
FII Holding32.07%▼ 1.01 pp17.09%▼ 0.08 pp
DII Holding31.74%▲ 1.02 pp15.25%▼ 0.88 pp
Public Holding9.35%▲ 0.02 pp22.13%▼ 0.5 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DR. REDDY S LABORATORIES and GRASIM INDUSTRIES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.